M Ventures — Full Portfolio

Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.

BiotechHealthtechWaltham, US

Rene Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Paul Clancy(Director)Daniel Curran(Director)Nancy Hong(Director)

Co-investorsBain Capital Life SciencesBay City CapitalF-Prime CapitalMRL Ventures FundRA CapitalRiverVest Venture Partners+4 more

Anjuna develops software for secure data sharing and confidential computing in cloud and AI environments.

AI & Machine LearningCloud ComputingCybersecurityDeep TechEnterprise SoftwareSan Francisco, US

Ayal Yogev(Founder/CEO)inSteve WeisYan M.(Founder)inYan Michalevsky(Founder)in

Co-investorsInsight PartnersSINEWAVE VENTURESAlpha Intelligence CapitalDCVC (Data Collective)Dorm RoomFounder Collective+3 more

Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech.

BiotechDeep TechMedical DevicesCulver City, US

James Heath(Director)Leroy Hood(Director)Andreas Jurgeit(Director)Heather Agnew(Executive Officer)Albert Luderer(Executive Officer, Director)Darren Cai(Director)

Co-investorsLegend CapitalAsset Management Company

Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US

George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inRobert Carson(Executive Officer, Director)Terry Lo(Director)inSeth Benson(Executive Officer)inSimona Levi(Executive Officer)in

Co-investorsARCH Venture PartnersNorthpond VenturesNovalis LifeSciences

Abselion develops measurement tools and a platform combining hardware, purpose-built assay formats, and software for biological measurements such as protein quantification.

BiotechDeep TechHardwareMedical DevicesCambridge, GB

Dr Ruizhi Wang(CEO)

Co-investorsCambridge Angels group

Actithera develops a chemistry platform for targeted cancer treatment that optimizes radiation dose absorption in tumors while reducing exposure to healthy tissue, with flexibility to pair different radionuclides based on tumor characteristics.

AI & Machine LearningBiotechDeep TechHealthtechMedical Devices

Darshan Dalal(Chief Medical Officer)in

Co-investorsHadean VenturesSofinnova Partners4BIO CapitalBioqube Ventures

Akili Interactive develops digital medicine delivered through video game experiences, combining neuroscience with interactive technology as a therapeutic treatment.

Digital HealthGamingHealthtech

Co-investorsDG Daiwa VenturesEvidity Health CapitalJAZZ Venture PartnersMachina VenturesWalnut Venture Associates

Altoida builds a multi-modal Digital NeuroMarker Platform that combines augmented reality, sensor fusion, and explainable AI in a 10-minute self-administered assessment to detect early signs of Mild Cognitive Impairment and Alzheimer's disease.

AI & Machine LearningDigital HealthMedical Devices

Co-investorsAlpana VenturesEisai Innovation, Inc.Hikma VenturesPolytech Ecosystem VenturesVI PartnersWhitecap Venture Partners

Co-investors5AM Ventures

Anavo Therapeutics is a biopharmaceutical company using its IGNITE platform to develop phosphatase-targeted allosteric modulators, addressing drug targets previously considered undruggable.

BiotechHealthtechLeiden, NL

Birgit Zech(CEO)in

Co-investorsTaiho Ventures, LLCBioqube VenturesInkef

Co-investorsNovartis Venture FundRA Capital

Artios develops DNA damage response (DDR)-based medicines targeting patients with high unmet need cancers.

BiotechHealthtechMedical Devices

Co-investorsAndera PartnersNovartis Venture FundPfizer Venture InvestmentsRA CapitalSofinnova PartnersSV Health Investors

Co-investorsKurma PartnersSofinnova PartnersSR One Capital Management

Developing The Benchtop Cell Factory, an end-to-end platform for Cell and Gene Therapy manufacturing using microfluidic technology.

Co-investorsAdBio partners

Co-investorsAdBio partners

beeOLED develops blue OLED emitters based on rare-earth (lanthanide) metal complexes, such as cerium or europium, stabilized with organic ligands and made vacuum-vaporizable for OLED display manufacturing.

Deep TechHardwareNew Materials

Dr. Carsten RotheDr. Volodymyr Senkovskyy

Co-investorsInnovation Industries

Biolinq develops the Shine sensor, a needle-free glucose monitor that measures glucose along with physical activity and sleep in a single wearable device.

Digital HealthHardwareMedical Devices

Jared Tangney(Founder)inRich Yangin

Co-investorsAble PartnersAlpha Wave GlobalAphelion CapitalAverin CapitalBOLD LongevityHikma Ventures+2 more

Co-investorsFountain Healthcare Partners

The page describes Photonic Fabric, an optical interconnect technology platform for the scale-up interconnect market that enables high-bandwidth, power-efficient links for AI data center infrastructure.

AI & Machine LearningDeep TechSector AgnosticSemiconductorsSanta Clara, US

Preetinder Virk(Chief Operating Officer)David Lazovsky(President and Chief Executive Officer)inKelyn Brannon(Chief Financial Officer)Philip Winterbottom(Chief Technology Officer)in

BoardLip-Bu Tan(Director)Alonso Galvan(Director)

Co-investorsFitz Gate VenturesIAG Capital PartnersKoch Disruptive TechnologiesSamsung Catalyst FundThe Engine VenturesTyche Partners+2 more

CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams.

BiotechDeep TechHardwareMedical DevicesAtlanta, US

Alla Zamarayeva, PhD(CEO & Co-founder)Todd Sulchek, PhD(CSO & Co-founder)Alex Alexeev, PhD(Co-founder)Alla Zamarayeva(CEO & Co-founder)Todd Sulchek(CSO & Co-founder)Alex Alexeev(Co-founder)

Co-investorsDynamk CapitalCota CapitalGreatPoint VenturesEmbark VenturesKhosla Ventures

ChemPower develops an abrasive-free chemical mechanical planarization (CMP) technology and materials for advanced semiconductor chip manufacturing.

Advanced ManufacturingCleantechNew MaterialsSemiconductorsBeaverton, US

Sudhanshu Misra(CEO)SV Babu(CTO)SUDHANSHU MISRA(Executive Officer, Director)

BoardSCOTT SHAW(Director)inOWEN LOZMAN(Director)JESSICA FREYER(Director)in

Co-investorsFoothill VenturesIntel CapitalPangaea Ventures Us Inc.Portland Seed FundRhapsody Venture PartnersTEL Venture Capital, Inc.+2 more

Concerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition.

AI & Machine LearningBiotechDeep TechCambridge, US

Jared Kehe(Executive Officer, Director)Cheri Ackerman(Executive Officer, Director)Bernardo Cervantes(Executive Officer, Director)inVera Schroeder(Director)

BoardSarah Luppino(Director)in

Co-investorsExcelestar VenturesGolden SeedsHorizons VenturesISVMassVenturesAxial VC

Corvic offers an enterprise AI platform that wraps frontier models with grounded playbooks, multi-agent workflows, persistent memory, and secure data handling to process structured and unstructured data at scale.

AI & Machine LearningData & InfrastructureEnterprise Software

Gurbinder Gill(Founder)in

Co-investorsFoothill VenturesLam CapitalSprout OakBosch VenturesK2 Access FundLDV Partners+1 more

Disco Pharmaceuticals develops cancer therapies using a cell surfaceome discovery technology to identify new molecular targets.

BiotechHealthtech

DNA Script develops enzymatic DNA synthesis technology, offered through its SYNTAX platform, that lets labs produce high-quality ssDNA oligos in-house and overnight.

BiotechDeep TechHardwareParis, FR

Thomas Ybert(Founder)in

Co-investorsCoatue ManagementKurma Partners

Electroninks develops and manufactures metal complex inks for semiconductor packaging, consumer electronics, and medical device manufacturing, offering improved conductivity and sustainability compared to traditional metallized inks.

Advanced ManufacturingHardwareNew MaterialsSemiconductorsAustin, US

Co-investorsBandgap VenturesIn-Q-Tel

Co-investorsPfizer Venture InvestmentsRA Capital

Co-investorsSEED Capital Denmark

FMC is a semiconductor company developing non-volatile memory solutions, spun from EU research institutions with R&D and manufacturing operations across Europe, the US, Japan, and Taiwan.

Deep TechHardwareSemiconductorsDresden, DE

Thomas Rueckes(Chief Executive Officer)Ayman Abouelwafa(Chief Product Officer)Norm Armour(Chief Operating Officer)Raj Jammy(President Global BU & CTO)

Co-investorsBosch VenturesDeepTech & Climate FondsRobert Bosch Venture CapitalTEL Venture Capital, Inc.HV Capitalimec.xpand+3 more

Co-investorsInnovestor VenturesSunstone Capital

Formo is a biotechnology company using fermentation and microbiology to create animal-free dairy products through molecular recreation rather than plant-based mimicry.

BiotechClimate TechFoodTechFrankfurt, DE

Raffa

Co-investorsFoodLabsGood Seed VenturesGrazia Equity GmbHGrey Silo VenturesLOWERCARBONLowercarbon Capital+4 more

FoRx Therapeutics is a biotechnology company focused on oncology drug discovery and clinical development, targeting the DNA Damage Response (DDR) network with small molecule inhibitors.

BiotechDeep TechHealthtechBasel, CH

Tarig Bashir(Chief Executive Officer (CEO))Jens Würthner(Chief Medical Officer (CMO))Frank Zenke(Chief Scientific Officer (CSO))

Co-investorsNovartis Venture FundPfizer Venture Investments

Future Fertility develops an artificial intelligence tool to assess egg quality for fertility treatment using machine learning analysis of oocyte health.

AI & Machine LearningBiotechDigital HealthFemTechHealthtech

Rene Bharti(Co-founder)Dr. Dan Nayot(Co-founder)

Co-investorsWhitecap Venture PartnersGaingelsSandpiper Ventures

Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis.

BiotechMedical Devices

Jennifer Jarrett(Chief Executive Officer & Board Director)Sherwin Sattarzadeh(Chief Operating Officer)Becker Hewes(Chief Medical Officer)Garrett Winslow(General Counsel)Jim Baker(Chief Corporate Affairs Officer)Brian Burkavage(Senior Vice President, Finance)

Co-investorsEIR VenturesHadean VenturesSEED Capital DenmarkSunstone CapitalYsios CapitalMaverick Ventures+1 more

Gamelynx develops cross-platform competitive games designed to be easy for audiences to watch.

ConsumerGamingLos Angeles, US

Alexander Mistakidis(Founder/CEO)inCarter Minshull(Founder/CTO)in

Co-investorsY Combinator

IKAS builds AI and modeling-based industrial intelligent manufacturing solutions for companies across the semiconductor supply chain (chip design, wafer fabrication, packaging and testing, equipment, and materials) as well as the power and energy sector.

Advanced ManufacturingAI & Machine LearningSemiconductorsBeijing, CN

Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials.

AI & Machine LearningBiotechDeep TechMedical DevicesParis, FR

Yann(Co-founder and CEO)Quentin(Co-founder and CSO)Nicolas(Co-founder and CTO)

Co-investorsDebiopharm Innovation FundOmnes Capital

ImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US

Peretz Partensky(Executive Officer, Director)Stuart Alexander Jacobson(Executive Officer, Director)Nina Horowitz(Chief Executive Officer)Rui Tostoes(Chief Technology Officer)Alicia Jackson(Director)

BoardDylan Morris(Director)

Co-investorsNFXGaingelsHealthspan CapitalInsight PartnersOne Way VenturesSand Hill Angels

Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.

BiotechDigital HealthMedical DevicesWaltham, US

Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)

BoardLaura Brass(Director)inKai Wucherpfennig(Director)

Co-investorsDC Investment PartnersLongwood FundMedical Excellence CapitalNovartis Venture FundOno Venture Investment, Inc.Solasta Ventures+2 more

iOmx Therapeutics is a biotech company developing novel cancer therapies.

AI & Machine LearningBiotechHealthtechMedical DevicesMunich, DE

Co-investorsSofinnova Partners

iOnctura is a clinical-stage drug development company developing precision oral small-molecule therapies targeting the tumor-stroma-immune interface, with a pipeline including roginolisib and cambritaxestat in cancers such as uveal melanoma and pancreatic cancer.

BiotechDeep TechHealthtechMedical Devices

Catherine Pickering(Co-Founder & CEO)inLars van der Veen(Co-Founder & CSO)inMichael Lahn(CMO)inElizabeth Holt(CBO)inSteven Sciuto(CFO)inMichelle Tsai(COO)in

Co-investorsInkef3B Future Health FundVI PartnersXGEN Venture

IonKraft, a spin-off from the Institute of Plastics Processing (IKV) at RWTH Aachen University, develops a barrier coating technology for mono-material plastic containers that provides the barrier and chemical resistance of multi-layer packaging while remaining fully recyclable.

Advanced ManufacturingCircular EconomyCleantechNew MaterialsAachen, DE

Bene(Co-Founder & Managing Director)inMonty(Co-Founder & Managing Director)

Co-investorsTechVision Fonds

Kivu Bioscience develops antibody-drug conjugate (ADC) therapeutics in clinical development, advancing a pipeline of cancer treatments through strategic partnerships and collaborations.

BiotechDeep TechHealthtechMedical Devices

Mohit Trikha(CEO)inSophia Randolph(Chief Medical Officer)in

Co-investorsBOMHealthCapRed Tree VentureBioGeneration VenturesNovo Holdings

LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.

AI & Machine LearningBiotechDeep TechLondon

Harrison Rickerby(Executive Officer, Director)

BoardJames Field(Executive Officer, Director)in

Co-investorsAcequia Capital (AceCap)Air Street CapitalBackedBeast VenturesChampion Hill VenturesGigafund+8 more

LabGenius develops EVA, an automated antibody discovery platform that uses machine learning and automation to identify and co-optimize complex therapeutic antibodies such as multispecifics.

AI & Machine LearningBiotechDeep Tech

Lightcast develops a single-cell functional analysis platform that uses droplet-based technology to profile cell function, biomolecule secretion, cell-cell interactions, and targeted cell killing at scale.

BiotechDeep TechHealthtech

Co-investors+ND CapitalIllumina VenturesLongwall Venture Partners LLPOMX VenturesARCH Venture Partners

Lumiode develops wafer-level μLED technology for ultra high-brightness, low-cost micro-displays used in wearable, automotive, and industrial products.

Deep TechHardwareSemiconductorsNew York, US

Nena Golubovic(Director)Vincent Lee(Executive Officer, Director)Ioannis Kymissis(Executive Officer, Director)Mark Halfman(Director)

BoardMichael Burychka(Director)in

Co-investorsAnzu Partners

Manticore Games develops and publishes Out of Time, a co-op roguelite video game, and operates the Core Platform, a user-generated content platform for games and interactive experiences.

Creator EconomyGamingSan Mateo, US

Frederic Descamps(Co-founder and Chief Executive Officer)inJordan Maynard(Co-founder and Chief Creative Officer)inChristian Wilson(Chief Technology Officer)inMatt Camp(Head of Product)in

BoardMitch Lasky(Director)in

Co-investors359 CapitalAtlassian VenturesBitkraft Esports VenturesCorrelation VenturesCrunchFundMaC Venture Capital+6 more

Medisafe is a medication engagement platform that helps pharmaceutical companies connect with patients beyond the prescription and improve treatment adherence.

Digital HealthHealthtechMedical DevicesBoston, US

Rotem Shor(Founder)

Co-investors7wire VenturesALIVE Israel HealthTech FundCorewell Health VenturesLool VenturesQualcomm VenturesSanofi Ventures+2 more

MemryX develops edge AI accelerator hardware and software solutions designed for efficient deployment across embedded systems.

AI & Machine LearningDeep TechHardwareSemiconductorsAnn Arbor, US

Dr. Wei Lu(Co-founder)

Co-investorseLab VenturesHemi Ventures, Llc

Metalenz develops metasurface optics technology for optical sensing in consumer and industrial devices.

Deep TechHardwareSemiconductorsStoneham, US

Robert Charles Devlin(Executive Officer, Director)Federico Capasso(Director)Rob Devlin(Founder)in

BoardXuhui Shao(Director)in

Co-investorsBantam GroupBraemar Energy VenturesFoothill VenturesGlobal BrainIntel CapitalNeotribe Ventures+6 more

Micropsi Industries develops MIRAI, an AI-vision software that guides industrial robots to perform tasks in changing factory conditions, including handling reflective and transparent objects.

Advanced ManufacturingAI & Machine LearningRobotics

Ronnie Vuine(Founder)in

Co-investorsAsgard - human Capital for AIConvergeProject A VenturesVsquared VenturesAhren Innovation Capitalcoparion+1 more

Mosa Meat is a company developing cultivated meat.

BiotechClimate TechFoodTech

Co-investorsAgronomicsArcTern VenturesBlue Horizon CorporationCollateral GoodMbuyu Capital PartnersStray Dog Capital+5 more

Co-investorsIQ Capital

NanoSyrinx develops a technology platform for biopharmaceutical applications, with expertise in drug discovery, cell therapy, and biologic development.

AI & Machine LearningBiotechDeep TechMedical DevicesCoventry, GB

Dr. Joe Healey(Founder)Dr. Nick Waterfield(Founder)Dr. Alexia Hapeshi(Founder)Joe(Founder and former CEO)Nick(Scientific Advisor and Co-founder)Thomas J. Farrell(CEO)

Co-investorsIQ CapitalOctopus VenturesSARAS CAPITALFuture Planet Capital

Co-investorsLool VenturesManiv Mobility

Neurable develops brain-computer interface (BCI) technology via smart headphones designed to enhance employee focus, productivity, and well-being in corporate settings.

AI & Machine LearningDeep TechHardwareHealthtechHR TechAnn Arbor, US

Dr. Ramses Alcaide(CEO and Co-Founder)Michael Thompson(Executive Officer)inAdam Eizenberg-Molnar(Cofounder)

Co-investorsCapital FactoryFundersClubGlobal BrainGoAhead VenturesHartmann CapitalHouston Angel Network+9 more

Co-investors5AM VenturesAndera PartnersAngelini VenturesCDP Venture CapitalIndaco Venture PartnersXGEN Venture

NovoLINC develops nanocomposite thermal interface materials designed to lower thermal resistance and improve heat dissipation in electronic chipsets.

Deep TechHardwareNew MaterialsPittsburgh, US

Robert Wenner(Executive Officer)Sheng Shen(Executive Officer, Director)

BoardTina Tosukhowong(Director)inEric Rosenblum(Director)inNing Li(Executive Officer, Director)inPaul Sheng(Director)

Co-investorsFoothill VenturesHitachi VenturesTDK VenturesCarnegie Mellon UniversityFathom Fund

NRG Therapeutics is a biotech company developing small-molecule drugs targeting the mitochondrial permeability transition pore (mPTP) for neurodegenerative diseases such as ALS and Parkinson's.

BiotechHealthtechLongevity

Neil Miller(CEO)inRichard Rutter(CSO)inGrant Hawthorne(COO)inClaus Sundgreen(Chief Medical Officer)inPaul Thompson(CDO)in

BoardJonathan Savidge(Independent Non Executive Chair)

Co-investorsCriteria Bio VenturesNovartis Venture FundSV Health InvestorsBritish Business BankDementia Discovery Fund

Co-investorsSanofi VenturesSAV (Scale Asia Ventures)

Nucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets.

AI & Machine LearningBiotechDeep Tech

Co-investorsOxford Science EnterprisesPfizer Venture InvestmentsBritish Patient CapitalJJDCPfizer Ventures

The page is a Vietnamese-language sports streaming site (90Phut TV / 90Phutr.tv, also called Vaoroi TV) offering free live football streaming links, match schedules, standings, results, news, and betting odds.

Media & EntertainmentSports TechHà Nội, VN

Co-investorsAisling CapitalNew Enterprise Associates (NEA)Sofinnova PartnersSofinnova Ventures

Outrun Therapeutics is a preclinical biotech developing small molecule E3 ligase inhibitors to stabilise tumour suppressor proteins for treating cancer and other diseases.

BiotechDeep TechDundee, GB

Satpal Virdee(Founder)

Co-investorsMC Healthcare Ventures

A tech startup operating in stealth mode on an undisclosed vision; it has developed Veluminum, a matte, velvet-like coating for aluminum.

Deep TechHardwareNew MaterialsSouth Pasadena, US

Jonathan Seamus Blackley(Executive Officer, Director)

BoardGregory Papadopoulos(Director)in

Co-investorsCambium CapitalMetaplanetNew Enterprise Associates (NEA)

BiotechLos Angeles, US

Aydogan Ozcan(Director, Promoter)Yair Rivenson(Executive Officer, Director, Promoter)Bauke Anninga(Director)in

BoardRobert Crutchfield(Director)Scott Barclay(Director)inGilbert Hakim(Director)

Co-investorsDCVC (Data Collective)Good Life Sciences Generations

Plexium is a targeted protein degradation company developing small molecule therapeutics for treating diseases with high unmet medical needs using their proprietary DELTA Discovery platform.

AI & Machine LearningBiotechDeep TechSan Diego, US

Michael Martin, Ph.D.(Chief Executive Officer, President)Jorge F. DiMartinoinMichael Martin(President, Chief Executive Officer)inStephen Mullennix(Executive Officer)in

BoardSerge Messerlian(Director)inCariad Chester(Director)in

Co-investorsCRV (Charles River Ventures)DCVC (Data Collective)Neotribe VenturesSoftBank Vision FundTCG CrossoverThe Column Group+1 more

Broomfield, US

Jason Sickler(Executive Officer, Director)Cory Pecinovsky(Executive Officer, Director)

BoardDaniel Franke(Director)inAdithyaram Narisimha(Director)Bernard Lupien(Director)

Co-investorsBuff Gold VenturesKoch Disruptive TechnologiesRhapsody Venture Partners

Polaris Electro-Optics develops a ferroelectric nematic glass (Polaris Glass) modulator platform that integrates with standard silicon photonics to build high-speed, energy-efficient optical interconnects.

Deep TechHardwareSemiconductorsBroomfield, US

Co-investorsKoch Disruptive TechnologiesRhapsody Venture Partners

Prexton Therapeutics was a biopharmaceutical company developing novel therapies for Parkinson's disease, including its lead mGluR4 modulator candidate foliglurax.

BiotechHealthtechMedical DevicesCopenhagen, DK

Co-investorsCardinal PartnersSeroba Life SciencesSunstone CapitalYsios Capital

PxE develops holographic imaging technology that captures fused RGB, infrared, and depth data from a single snapshot using one lens, sensor, and chip.

Deep TechHardwareSemiconductors

Co-investorsKoch Disruptive Technologies

Quintessent develops optical connectivity solutions to address chip-to-chip communication bottlenecks in large-scale computing and AI systems.

AI & Machine LearningCloud ComputingDeep TechHardwareSemiconductorsSanta Barbara, US

Alan Liu(CEO, Co-Founder & Board Member)inBrian Koch(VP of Engineering & Co-Founder)inJohn Bowers(Chairman of the Board & Co-Founder)

Co-investorsEntrada VenturesFoothill VenturesOUP (Osage University Partners)Sierra Ventures

ReproNovo is a biopharmaceutical company developing therapies for fertility and women's health, targeting male infertility (low testosterone/sperm production), female fertility (embryo implantation and IVF/ICSI success), and adenomyosis.

BiotechFemTechHealthtech

Co-investorsJeito CapitalYsios Capital

BiotechGreenville, US

Kevin Weeks(Executive Officer, Director)Katherine Warner(Executive Officer)Joshua Resnick(Director)Michael Solomon(Director)John Gustofson(Director)

BoardMike Dial(Director)in

Co-investorsIllumina VenturesMC Healthcare VenturesPappas CapitalSV Health InvestorsDementia Discovery FundHatteras Venture Partners+1 more

Rewind Therapeutics is a biotech company developing first-in-class remyelination therapeutics that aim to repair the myelin sheath in patients with diseases such as multiple sclerosis, optic neuritis, and nerve injuries.

BiotechDeep TechHealthtechLeuven, BE

Co-investorsBoehringer Ingelheim Venture FundPMVSunstone Capital

SEEQC develops a digital quantum computing platform that integrates the core functions of a quantum computer—including qubits and classical control logic—onto superconducting cryogenic chips, aiming to scale qubits without added complexity.

Deep TechQuantum ComputingSemiconductorsElmsford, US

Oleg Mukhanov(CSO)inJohn Levy(CEO)inRaja Bal(CFO)Tim Anglim(Executive Officer)Matthew Hutchings(Executive Officer)Shu-Jen Han(CTO)

Co-investorsBlueYard CapitalNordicNinjaEQT VenturesArcTern VenturesBooz Allen VenturesCambium Capital+5 more

Sonde develops voice-based biomarker technology to detect health conditions early through analysis of speech patterns on everyday devices.

AI & Machine LearningDigital HealthHealthtech

David Liu(Chief Executive Officer)James Harper(Chief Strategy Officer)Yogendra Jain(Chief Technology Officer)Erik Larsen(Senior Vice President, Clinical Development & Customer Success)Sanjay Pothen(Chief Financial Officer)Garrett Bussiere(Vice President of Strategic Partnerships)

Co-investorsEvidity Health CapitalMC Healthcare Ventures

STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.

BiotechHealthtechMedical Devices

Co-investorsFast Track InitiativePfizer Venture InvestmentsSeroba Life SciencesTaiho Ventures, LLCUTokyo Innovation Platform Co. Ltd.Cambridge Innovation Capital

Synaffix develops antibody-drug conjugate (ADC) technology, providing linker-payload platforms that attach small-molecule, peptide, and protein-based payloads to antibodies for use in targeted cancer therapies.

BiotechDeep TechHealthtech

Co-investorsBOMBioGeneration Ventures

SynSense develops neuromorphic intelligence chips and vision systems for human-machine and brain-computer interfaces, optimizing for ultra-low power consumption and latency in edge computing applications.

AI & Machine LearningDeep TechSemiconductors

Dr. Ning Qiao(Founder)Prof. Giacomo Indiveri(Founder)

Co-investorsHuaweiAusvic Capital

Theolytics develops systemically deliverable immunotherapies based on oncolytic adenoviruses designed to target solid tumours and their supporting microenvironment.

BiotechHealthtech

Co-investorsEpidarex CapitalOxford Science EnterprisesSound BioventuresTaiho Ventures, LLC

Advanced ManufacturingDeep TechSemiconductorsSeattle, US

Jonathan L Herlocker(Executive Officer, Director)Jon Herlocker(Founder)inMatthew R McLaughlin(Executive Officer, Director)

BoardAshmeet Sidana(Director)in

Co-investorsClear VenturesDN CapitalEngineering Capital

Tipe is a headless content management system designed for developers, offering schema-based content modeling and framework integrations for building web applications.

Data & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Scott Moss(Founder/CEO)inMichael Moss(Founder/CPO)inPatrick Stapleton(Founder/CTO)in

Co-investorsY CombinatorCRV (Charles River Ventures)Precursor Ventures

RNA therapeutics; NASDAQ TBIO, acquired by Sanofi.

Co-investorsMRL Ventures FundSofinnova Ventures

Platform company targeting selective clearance of intracellular protein aggregates in neurodegenerative disease.

Co-investorsCambridge Innovation CapitalPfizer Venture InvestmentsStart Codon

UNISERS develops automated contamination detection systems for semiconductor wafer manufacturing using optical detection and AI algorithms to identify nanoparticles and defect sources, helping chip makers improve production yields.

Advanced ManufacturingAI & Machine LearningDeep TechSemiconductorsZurich, CH

Co-investorsIntel CapitalSwisscom VenturesSICTIC

Co-investorsPfizer Venture InvestmentsTCG Crossover

Enara Bio is a biopharmaceutical company developing cancer immunotherapies for solid tumors, using its EDAPT platform to discover novel tumor-specific "Dark Antigens" from genomic dark matter and its EnTiCE platform to build bispecific T-cell engagers.

Biotech

Co-investorsPfizer Venture Investments

Wiliot manufactures battery-free Bluetooth sensors for supply chain visibility and develops AI-powered platform software that converts continuous sensing data into real-time supply chain intelligence.

AI & Machine LearningIoTLogistics & Supply Chain

Co-investors83NorthCerity Partners VenturesGrove VenturesMaersk GrowthNorwest Venture PartnersQualcomm Ventures+2 more